These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18161796)

  • 21. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts.
    Borgogna C; Toniutto P; Smirne C; Azzimonti B; Rittà M; Avellini C; Fabris C; Landolfo S; Gariglio M; Pirisi M
    Histopathology; 2009 Jun; 54(7):837-46. PubMed ID: 19635103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.
    Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K
    Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infection.
    Robaeys G; Nevens F; Stärkel P; Colle I; Van Eyken P; Bruckers L; Van Ranst M; Buntinx F
    Transplant Proc; 2009 Mar; 41(2):589-94. PubMed ID: 19328933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance.
    Fildes JE; Yonan N; Leonard CT
    Transpl Immunol; 2008 Apr; 19(1):1-11. PubMed ID: 18346631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of recurrent hepatitis C and what influences this.
    Gane EJ
    Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective analysis of the natural course of donor chimerism including the natural killer cell fraction after liver transplantation.
    Verdonk RC; Haagsma EB; Jongsma T; Porte RJ; Roozendaal C; van den Berg AP; Hepkema BG
    Transplantation; 2011 Aug; 92(4):e22-4. PubMed ID: 21814126
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of HLA antigens in liver transplantation with special reference to cellular immune reactions.
    Markus BH; Duquesnoy RJ; Blaheta RA; Scholz M; Encke A
    Langenbecks Arch Surg; 1998 Mar; 383(1):87-94. PubMed ID: 9627177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult ABO-incompatible liver transplantation by intraportal transfusion of donor-specific antigen: a case report.
    Sato Y; Yamamoto S; Oya H; Nakatsuka H; Kobayashi T; Watanabe T; Hara Y; Kokai H; Hatakeyama K
    Transplant Proc; 2008 Oct; 40(8):2811-4. PubMed ID: 18929867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive tests in the post-liver transplantation setting.
    Cholongitas E; Senzolo M; Quaglia A; Patch D; Dhillon AP; Burroughs AK
    Liver Transpl; 2007 Apr; 13(4):626-7; author reply 628-9. PubMed ID: 17394169
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
    Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
    Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
    Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?
    Suneetha PV; Mederacke I; Heim A; Bastürk M; Cornberg M; Strassburg CP; Manns MP; Wedemeyer H
    Liver Transpl; 2008 Aug; 14(8):1225-7. PubMed ID: 18668659
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro mitogen-stimulated T-cell from hepatitis C virus-positive liver transplantation candidates, increases T-cell activation markers and T-cell proliferation.
    Canivet C; Böhler T; Galvani S; Péron JM; Muscari F; Alric L; Barange K; Salvayre R; Negre-Salvayre A; Durand D; Suc B; Izopet J; Thomsen M; Rostaing L; Kamar N
    Transpl Immunol; 2008 May; 19(2):112-9. PubMed ID: 18503886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.